Ryan White Program Disruptions: City-Level Impact Projections
What happens if Ryan White funding is interrupted or eliminated? Modeling impacts on HIV care outcomes across major US metropolitan areas.
Ann Intern Med, 2025
ExploreHIV policy & population health
JHEEM provides evidence for HIV policy decisions through calibrated mathematical modeling across US metropolitan areas and states.
Explore projections for your city or state.
What happens if Ryan White funding is interrupted or eliminated? Modeling impacts on HIV care outcomes across major US metropolitan areas.
Ann Intern Med, 2025
ExploreStatewide projections of Ryan White funding disruption, providing jurisdictional insights for policy makers.
AJPH, 2026 · CROI, 2026
ExploreWhat is the epidemiological impact of ending CDC-funded testing? Modeling cessation and interruption scenarios.
Clin Infect Dis, 2026
ExploreHow will the HIV population age over the next 15 years? State-level projections from 2025 to 2040.
JAMA Netw Open, 2026
ExploreWhat are the economic and epidemiological consequences of ending ADAP? Compare downstream HIV care costs with program spending avoided through 2035.
Working paper
ExploreForster RM, Schnure M, Balasubramanian R et al.medRxiv
Zalesak A, Kasaie P, Dansky Z et al.JAMA Network Open
Schnure M, Forster R, Jones JL et al.American Journal of Public Health
We use mathematical modeling to understand and predict HIV transmission and the impact of interventions across local populations. The simulated population is stratified by age, race, sex, sexual behavior, and drug use, and is calibrated to real-world HIV surveillance data under the Ending the HIV Epidemic initiative—enabling projections of how policy and funding decisions may shape future transmission.
This research is supported by grants from the National Institute of Mental Health, the National Institute of Allergy and Infectious Diseases, and the National Institute on Minority Health and Health Disparities.
A note on the name: JHEEM was previously published as the “Johns Hopkins Epidemiology and Economic Model.” The acronym is retained; the name was revised in 2026 to reflect use beyond a single institution. Citations to the prior name remain equivalent for attribution, reproducibility, and continuity.